Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Data Collection I

Data Collection I

Data collection gathers information needed to make accurate judgments about a patient's present condition. During a health history interview, subjective data is collected from the patient, their caregivers, or family members, and objective data is collected through observations and physical assessment. Patients are the primary source of subjective data. Thus information gathered from patients through interviews, observations, and physical examination is primary data. Secondary sources of...

Data Reporting and Recording

Data Reporting and Recording

Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...

Ethical Standards I

Ethical Standards I

The American Nurses Association (ANA) created and implemented the first nationally accepted Code of Ethics for Nurses with Interpretive Statements. The Code of Ethics is a living document regularly updated by the ANA and establishes an ethical standard that is non-negotiable for nurses in all roles and settings.
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...

Data Collection III

Data Collection III

The physical assessment examines the patient for objective data that defines the patient's condition, and aids in formulating the nursing care plan. The purpose of physical assessment is a health status appraisal, which includes identifying health problems, and establishing a database for nursing intervention.
The principles to begin the physical assessment include conducting a comprehensive or problem-related history in a quiet, well-lit room, emphasizing privacy and comfort for the...

Data Validation

Data Validation

Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...

Data Validation

Data Validation

Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Kaempferitrin attenuates DSS-induced colitis by promoting ubiquitination-mediated degradation of the nuclear factor kappa B p65.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

Same author

Recent Advances in Natural Products for Colitis: Mechanisms and Translational Perspectives.

Veterinary sciences·2026

Same author

Modulating Host Lipid Metabolism via Gut Microbiota: Therapeutic Potential of Plant-Derived Compounds.

Phytotherapy research : PTR·2026

Same author

Maladaptive appearance perfectionism and psychosocial distress among cosmetic dermatology patients.

Frontiers in public health·2026

Same author

L-Theanine activates the mTOR signaling pathway through TAS1R1-FRMD6 to promote milk synthesis in bovine mammary epithelial cells.

The Journal of nutritional biochemistry·2026

Same author

Use and Influencing Factors of mHealth Services Among Adult Survivors of Cancer: Cross-Sectional Survey Study.

Journal of medical Internet research·2026

Same journal

Impact of tranexamic acid on early allograft dysfunction following liver transplantation: study design for a prospective randomized controlled trial.

Trials·2026

Same journal

SWAT 116: the effectiveness of an infographic to improve trial recruitment-a randomised study within a trial (SWAT).

Trials·2026

Same journal

Nurse counselors' experiences of recruitment and retention of female sex workers in a HIV vaccine trial: a qualitative study from urban Tanzania.

Trials·2026

Same journal

Treatment of genitourinary syndrome of menopause with fractional CO₂ laser versus fractional microablative radiofrequency: study protocol for a double-blind, randomised, non-inferiority trial.

Trials·2026

Same journal

TaILOR: a randomised trial to compare the clinical and cost-effectiveness of a patient-initiated follow-up (PIFU) strategy compared to standard care pathways in people with inflammatory arthritis: a study protocol.

Trials·2026

Same journal

Scaling up community-based non-communicable disease research into practice in Pokhara Metropolitan City of Nepal (SCALE-NCD) trial: study protocol for a cluster-randomized controlled trial.

Trials·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 7, 2026

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms

Published on: May 9, 2017

Challenges to complete and useful data sharing.

Lawrence Mbuagbaw^1,2,3, Gary Foster^4,5, Ji Cheng⁵

¹Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada. mbuagblc@mcmaster.ca.

|February 16, 2017

Summary

This summary is machine-generated.

Sharing clinical trial data promotes transparency but faces practical hurdles. Addressing issues like multi-center consent and data quality proactively can improve data sharing and secondary analyses.

Keywords:

Data sharing Fairness Jurisdiction Multicentre Programmatic Remote access

More Related Videos

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Published on: August 25, 2018

Related Experiment Videos

Last Updated: Mar 7, 2026

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms

Published on: May 9, 2017

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Published on: August 25, 2018

Area of Science:

Clinical Trials
Data Science
Medical Research

Background:

Clinical trial data sharing enhances transparency and maximizes data utility for secondary analyses.
However, data sharing presents challenges, including investigator burden and variable quality of secondary analyses.

Discussion:

Practical impediments to data sharing include multi-center consent requirements, technical limitations of remote access platforms, and data transfer restrictions.
Cross-jurisdictional data governance, use of routine care data, multilingual datasets, and poor data quality further complicate secondary analyses.

Key Insights:

Proactive identification and mitigation of data sharing barriers are crucial for effective data utilization.
Anticipating data sharing needs during trial design can prevent future obstacles.

Outlook:

Integrating solutions for these practical issues into ongoing data sharing discussions is essential.
Streamlining data sharing processes will facilitate robust secondary analyses and advance medical research.